1 – 10 of 73
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE ε4, sex and age
Ayton, Scott ; Janelidze, Shorena LU ; Roberts, Blaine ; Palmqvist, Sebastian LU
; Kalinowski, Pawel
; Diouf, Ibrahima
; Belaidi, Abdel A.
; Stomrud, Erik
LU
; Bush, Ashley I.
and Hansson, Oskar
LU
(2021)
In Progress in Neurobiology
198.
Mark
-
Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease
Johansson, Maurits LU ; Stomrud, Erik LU ; Insel, Philip S. LU ; Leuzy, Antoine LU ; Johansson, Per Mårten LU ; Smith, Ruben LU ; Ismail, Zahinoor ; Janelidze, Shorena LU ; Palmqvist, Sebastian LU
and van Westen, Danielle
LU
, et al.
(2021)
In Translational Psychiatry
11(1).
Mark
-
Associations of Plasma Phospho-Tau217 Levels with Tau Positron Emission Tomography in Early Alzheimer Disease
Janelidze, Shorena LU ; Berron, David LU ; Smith, Ruben LU ; Strandberg, Olof LU ; Proctor, Nicholas K. ; Dage, Jeffrey L. ; Stomrud, Erik LU ; Palmqvist, Sebastian LU
; Mattsson-Carlgren, Niklas
LU
and Hansson, Oskar
LU
(2021)
In JAMA Neurology
78(2).
p.149-149
Mark
- Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease
-
Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease
Hall, Sara LU ; Janelidze, Shorena LU ; Londos, Elisabet LU ; Leuzy, Antoine LU ; Stomrud, Erik LU ; Dage, Jeffrey L. and Hansson, Oskar LU
(2021)
In Movement Disorders
36(3).
p.767-771
Mark
-
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Cicognola, Claudia LU
; Janelidze, Shorena
LU
; Hertze, Joakim
LU
; Zetterberg, Henrik
LU
; Blennow, Kaj
LU
; Mattsson-Carlgren, Niklas
LU
and Hansson, Oskar
LU
(2021)
In Alzheimer's Research and Therapy
13(1).
Mark
- 2020
-
Plasma P-tau181 in Alzheimer’s disease : relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
Janelidze, Shorena LU ; Mattsson, Niklas LU ; Palmqvist, Sebastian LU
; Smith, Ruben
LU
; Beach, Thomas G.
; Serrano, Geidy E.
; Chai, Xiyun
; Proctor, Nicholas K.
; Eichenlaub, Udo
and Zetterberg, Henrik
LU
, et al.
(2020)
In Nature Medicine
26(3).
p.379-386
Mark
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease : a diagnostic performance and prediction modelling study using data from four prospective cohorts
-
Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease
Mengel, David ; Janelidze, Shorena LU ; Glynn, Robert J. ; Liu, Wen ; Hansson, Oskar LU
and Walsh, Dominic M.
(2020)
In Annals of Neurology
88(5).
p.878-892
Mark
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease